EVIIVE AG
PrivateLast Round
Accelerator
Dec 27, 2024
Total Funding Raised
$462,800
Company Overview
EVIIVE AG is a biotech company developing a next-generation liquid biopsy platform using extracellular vesicle (EV) analysis and machine learning to guide personalized treatment decisions in immuno-oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EVIIVE AG Comparables
Compare EVIIVE AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mursla Bio | 77% | |
| Exosomics S.p.A. | 74% | |
| Mercy BioAnalytics | 70% |
EVIIVE AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Dec 27, 2024 | ||||
| Grant | Oct 1, 2024 | ||||
| Grant | Nov 1, 2023 | ||||
| Grant | Sep 1, 2023 | ||||
| Grant | Dec 16, 2022 |
EVIIVE AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gebert Rüf Stiftung | Grant |
| Werner Siemens-Stiftung | Grant |
| Swiss National Science Foundation | Grant |
| Innosuisse | Grant |
| University of Zurich | Grant |
| Venture Kick | Accelerator, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors increased 429% MoM.
- Nov 7, 2025
Monthly visitors increased 147% MoM.
EVIIVE AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about EVIIVE AG's valuation, stock price, and market status.
Is EVIIVE AG a public or private company?
EVIIVE AG is a private company.
What is the current stock price of EVIIVE AG?
EVIIVE AG is a private company with no public stock price. No recent secondary market data is available.
How much is EVIIVE AG worth (valuation)?
Valuation information for EVIIVE AG is not publicly available.
Can I buy EVIIVE AG stock?
EVIIVE AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was EVIIVE AG's last funding round?
EVIIVE AG's most recent funding round was Accelerator on December 27, 2024.
Who are the main investors in EVIIVE AG?
Key investors in EVIIVE AG include Gebert Rüf Stiftung, Werner Siemens-Stiftung, Swiss National Science Foundation, Innosuisse, University of Zurich.
Will EVIIVE AG IPO soon?
No public IPO plans have been announced for EVIIVE AG.
How can I track EVIIVE AG secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor EVIIVE AG's secondary market activity and sign up for updates.